top of page


ABOUT SYNTHERIX
SYNTHERIX is a Biotechnology company set up to develop and commercilalise ONKONEK, a drug that kills cancer cells in a totally new and different way by causing them to run out of energy.
A Key Breakthrough
In Understanding Cancer
CURRENT THERAPIES ARE NOT THE COMPLETE ANSWER
CHEMOTHERAPY tries to kill cancer cells by preventing them dividing
Chemotherapy has well known side effects damaging normal tissues such as hair, blood, bowel etc

Even drugs attacking specific oncogenes are not without side effects

Both treatments are able to slow the growth rate of cancer but rarely cure it

MODERN IMMUNOTHERAPY
Despite initial successes against melanoma, immunotherapy is now starting to show discouraging results in other cancers and large Biopharma have culled over 40 immuno-oncology projects in the last 6 months.
THE BENEFITS

bottom of page